DGAP-News: CompuGroup Medical SE confirms dividend on prior year level

- Annual General Meeting remains scheduled for May 13, 2020

- Dividend on prior year level at EUR 0.50

- Timetable for change of legal form unchanged

Koblenz. With today's publication of the Annual Report 2019, CompuGroup Medical SE (CGM) announced that the Management Board and Supervisory Board intend to propose to the annual general meeting a dividend of EUR 0.50 per share to be paid, on same level as last year.

Furthermore, CGM continues to adhere to the timetable for the intended change of the Company's legal form from a European Company (SE) into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) with the proposal of a corresponding resolution by the annual general meeting on 13 May 2020.

The preliminary figures for the 2019 financial year and the guidance for 2020 were already announced on 5 February 2020.

The Annual Report is available on the company's website under Investor Relations.
 

About CompuGroup Medical SE
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of MEUR 746 in 2019, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. More than 5'600 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

You can reach our press archive at:

Press releases CGM Group:
https://www.cgm.com/corp/presse/presseinformationen/Presse.en.jsp

 

CompuGroup Medical SE Contact for media representatives:
Michael Franz
Head of Brand Communication
P +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100
E-mail: press@cgm.com Contact for analysts and investors:
Claudia Thomé
Head of Investor Relations
P +49 (0) 261 8000-7030
F +49 (0) 261 8000-3200
E-mail: claudia.thome@cgm.com